Legal & General Group’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.7M Buy
156,143
+6,810
+5% +$220K ﹤0.01% 1532
2025
Q4
$5.18M Buy
149,333
+23,577
+19% +$832K ﹤0.01% 1544
2025
Q3
$4.56M Buy
125,756
+2,517
+2% +$85.5K ﹤0.01% 1629
2025
Q2
$3.87M Sell
123,239
-18,436
-13% -$573K ﹤0.01% 1664
2025
Q1
$4.2M Buy
141,675
+4,800
+4% +$144K ﹤0.01% 1608
2024
Q4
$4.04M Buy
136,875
+20,163
+17% +$637K ﹤0.01% 1682
2024
Q3
$3.63M Sell
116,712
-3,805
-3% -$138K ﹤0.01% 1719
2024
Q2
$4.08M Buy
120,517
+84,472
+234% +$4.31M ﹤0.01% 1624
2024
Q1
$2.34M Sell
36,045
-250
-0.7% -$17.2K ﹤0.01% 1873
2023
Q4
$2.48M Buy
36,295
+8,609
+31% +$447K ﹤0.01% 1844
2023
Q3
$1.44M Buy
27,686
+3,712
+15% +$220K ﹤0.01% 2044
2023
Q2
$1.44M Buy
23,974
+17,920
+296% +$1.02M ﹤0.01% 2071
2023
Q1
$299K Buy
6,054
+304
+5% +$17.1K ﹤0.01% 2450
2022
Q4
$328K Sell
5,750
-9,599
-63% -$540K ﹤0.01% 2439
2022
Q3
$719K Sell
15,349
-443
-3% -$21.1K ﹤0.01% 2246
2022
Q2
$589K Sell
15,792
-6,577
-29% -$214K ﹤0.01% 2305
2022
Q1
$667K Hold
22,369
﹤0.01% 2322
2021
Q4
$765K Sell
22,369
-2,908
-12% -$105K ﹤0.01% 2305
2021
Q3
$933K Buy
25,277
+6,186
+32% +$209K ﹤0.01% 2265
2021
Q2
$725K Buy
+19,091
New +$737K ﹤0.01% 2265

Other funds holding IMCR